Indoor volatile organic compounds (VOCs) have been associated with asthma, but there is little epidemiologic work on ambient exposures, and no data on relationships between respiratory health and exhaled breath VOCs, which is a biomarker of VOC exposure. We recruited 26 Hispanic children with mild asthma in a Los Angeles community with high VOC levels near major freeways and trucking routes. Two dropped out, three had invalid peak expiratory flow (PEF) or breath VOC data, leaving 21. Children filled out symptom diaries and performed PEF maneuvers daily, November 1999-January 2000. We aimed to collect breath VOC samples on asthma episode and baseline symptom-free days, but six subjects only gave samples on symptom-free days. We analyzed 106 breath samples by GC-MS. Eight VOCs were quantifiable in 475% of breath samples (benzene, methylene chloride, styrene, tetrachloroethylene, toluene, m,p-xylene, o-xylene, and p-dichlorobenzene). Generalized estimating equation and mixed linear regression models for VOC exposure-response relationships controlled for temperature and respiratory infections. We found marginally positive associations between bothersome or more severe asthma symptoms and same day breath concentrations of benzene [odds ratio (OR) 2.03, 95% confidence interval (CI) 0.80, 5.11] but not other breath VOCs. Ambient petroleum-related VOCs measured on the same person-days as breath VOCs showed notably stronger associations with symptoms, including toluene, m,p-xylene, o-xylene, and benzene (OR 5.93, 95% CI 1.64, 21.4). On breath sample days, symptoms were also associated with 1-h ambient NO 2 , OR 8.13 (1.52, 43.4), and SO 2 , OR 2.36 (1.16, 4.81). Consistent inverse relationships were found between evening PEF and the same ambient VOCs, NO 2 , and SO 2 . There were no associations with O 3 . Given the high traffic density of the region, stronger associations for ambient than for breath VOCs suggest that ambient VOC measurements were better markers for daily exposure to combustion-related compounds thought to be causally related to acute asthma. Alternatively, the low sample size of symptom responses (15-21 responses per 108 breath samples) may have led to the nonsignificant results for breath VOCs.
Introduction
Epidemiological studies of asthma and outdoor air pollution have primarily focused on principal criteria air pollutants regulated by the US EPA, namely O 3 , particulate matter (PM), CO, NO 2 , and SO 2 . The EPA has established National Ambient Air Quality Standards (NAAQS) for these pollutants and has set up a national monitoring network. The lack of other pollutant monitoring data and the regulatory focus partly explain the paucity of epidemiological data concerning other exposures such as air toxics, which include a large number of aromatic and other hydrocarbons. The primary focus of the present research is on a specific set of air toxics that are volatile organic compounds (VOCs).
Some VOCs may be involved in inflammatory processes in asthma through irritant-induced induction of inflammatory mediators that trigger nonadrenergic, noncholinergic nerves to release tachykinins, that is, neurogenic inflammation (Meggs, 1993; American Thoracic Society, 1999) . Tachykinins influence bronchomotor tone, mucus secretion, and venular permeability (Maggi et al., 1995) . This process may serve to enhance ongoing inflammation in the asthmatic lung caused by known immune triggers such as allergens. Experimental evidence in controlled human exposure studies of VOCs is limited. One study of 14 healthy nonsmoking young adult men showed an increased neutrophils in nasal lavage from VOC mixtures (Koren et al., 1992) , while another showed no effect on forced expiratory volume in 1 s (FEV 1 ) or histamine reactivity in 11 mild asthmatic adults (Molhave et al., 1986) .
Associations between indoor home VOCs and asthma or related respiratory outcomes have been shown in two crosssectional studies (Norba¨ck et al., 1995; Wieslander et al., 1997) and a prospective study of 266 newborn children (Diez et al., 2000) . These studies may have been subject to unmeasured confounding by other indoor causal agents, including aeroallergens and environmental tobacco smoke, which can contain benzene among other air toxics (Leikauf et al., 1995) . There is even less information to evaluate respiratory health effects from outdoor ambient VOCs, which include some of the same compounds from indoor sources. Ware et al. (1993) conducted a cross-sectional study of ambient VOCs exposures in 8549 children living in the Kanawha Valley, WV, a center for chemical manufacture. Petroleum-related and industrial-process-related VOCs showed weak but statistically significant associations with reported respiratory symptoms, while asthma diagnoses were associated only with petroleum-related VOCs.
To address the paucity of information on acute asthma in children and outdoor ambient air toxics exposures, we examined the longitudinal relationship of the daily asthma severity among asthmatic children to VOC exposures. In a previous analysis, we found positive associations of symptoms with outdoor ambient measurements of criteria air pollutants (O 3 , NO 2 , SO 2 , PM 10 ), elemental and organic carbon fractions of PM 10 , and VOCs (benzene, ethylbenzene, formaldehyde, acetaldehyde, acetone, 1,3-butadiene, tetrachloroethylene, toluene, mp-xylene, and o-xylene) (Delfino et al., 2003) . The present exploratory investigation is the first epidemiologic study to evaluate the relationship of acute asthma outcomes to exhaled breath measurements of VOC. Selected VOCs were measured in exhaled breath samples and at outdoor stationary monitoring sites. Exhaled breath measurements have the potential to be markers of lower VOC exposures in community settings as exemplified by EPA's TEAM Studies (Wallace et al., 1996) . Subjects were school children with physician-diagnosed asthma living in the Huntington Park area of East Los Angeles County. This region has VOC levels among the highest in the Los Angeles air basin (SCAQMD, 2000) and is flanked by major freeways and trucking routes.
Methods

Design
This is a panel study testing the relationship of daily repeated measures of health outcomes to air pollutant exposures. Health outcomes included asthma symptoms and peak expiratory flow rate (PEF) reported in daily diaries. Subjects were Hispanic children with asthma who lived and attended school in the Huntington Park region during the follow-up period of November 4, 1999 through January 23, 2000. Monitoring data indicated that these 3 months would have the highest monthly average concentrations of VOCs, in part due to episodes of air stagnation (SCAQMD, 2000) . Health outcomes and outdoor air pollution were measured daily over the 3 months yielding a daily repeated time series. However, present analyses focus on the subset of person-days of observation when breath VOC samples were obtained. We compare strengths of associations with health outcomes for breath versus ambient VOC measurements.
After an initial training session when the baseline questionnaires were administered, all subjects were again familiarized with procedures just before the start of the panel. Recruited subjects performed daily tasks for 5-10 days before the start of air pollution monitoring on November 4, 1999, except for one subject who did this for 3 days. This provided an opportunity for subjects to become familiar with the study procedures and for any problems in completing tasks to be resolved with field staff. Retraining was administered for subjects after the first week for diary and PEF procedures that appeared to be performed incorrectly. Subjects and at least one parent/legal guardian were followed up weekly at their homes to insure the accuracy of diaries and compliance with the study protocol. Monetary incentives of $3 per day were used to enhance continued participation and compliance.
Population
We aimed to follow a cohort of 24 pediatric subjects recruited through referrals from area schools. Eligibility criteria were as follows:
1. a minimum 1 year history of physician-diagnosed asthma; 2. age 10-15 years, to recruit children who are old enough to complete diaries, but too young to drive or to work, to minimize nonambient VOC exposures; 3. nonsmokers who live in nonsmoking households, to avoid confounding by tobacco smoke; 4. home address and school address within a 3 mile radius of the central air monitoring site; 5. at least two symptomatic days per week requiring asneeded b-agonist inhaler use to treat bothersome symptoms that may interfere with daily activities.
The fifth criterion was relaxed after it became evident that the recruitment target of 24 subjects would not be met in time for the high VOC exposure season unless subjects with more intermittent asthma were recruited. Also, two 16 year olds were recruited who did not have regular use of cars and did not have regular jobs.
We recruited 26 children, all of Mexican or Central American descent, reflecting the school and community population. One 12-year-old male dropped out after 5 weeks; the reason given was an extended out-of-town family trip. Diary completion was poor with this subject. Another 10-year-old male did not properly complete the asthma diary despite repeated attempts at retraining. These two subjects were excluded from further study. Remaining subjects were located within a 2.6-mile radius study area in the communities of Huntington Park, Maywood, Bell, South Gate, and Florence-Graham, except one subject at 3.8 miles. Herein, the area of study will be referred to as the Huntington Park region. VOCs in the Huntington Park region derive mostly from local auto and truck traffic, but also from local light industry and transport from upwind sources.
Subjects were instructed to perform PEF maneuvers three times in the morning and three times in the evening, and write results in a diary. Replication of PEF data for all three maneuvers may actually occur on occasion, but our suspicion of noncompliance increases when the phenomenon occurs repeatedly. This was found for 34-41% of the PEF data for two subjects. These subjects had most remaining maneuvers in an exact three-number sequence or odd PEF values that cannot be reasonably read off the meter. We concluded that their data were highly suspect and excluded them from analyses. Respiratory infection data for two other subjects appeared to be in error because of off and on appearance of responses from day to day, inconsistent with the usual course of respiratory infections. Therefore, we could not use respiratory infection data as a covariate for these two subjects. Other data suggested that they might have been confused about diary questions in general. One other subject did not give any useable breath samples, which left 21 subjects with breath VOC and outcome data for univariate regression models and 19 subjects for models including the respiratory infection variable.
The institutional review boards of the University of California, Irvine, and Los Amigos Research and Education Institute, approved the study protocol. Informed written consent in Spanish or English was obtained from subjects and their legal guardians. Questionnaires and recruitment flyers were translated into Spanish. Initially, subjects volunteered to participate for 2 months from November to December 1999. A total of 11 subjects later volunteered to continue through the month of January in order to increase the number of breath samples collected.
Health Outcomes
Subjects were trained to report their daily severity of asthma on a numerical scale based on its impact on quality of life, that is, interference with their own usual activities. Subjects rated asthma symptoms (cough, wheeze, sputum production, shortness of breath, and chest tightness) in terms of their combined severity on a scale from 0 to 5, as follows: 0 ¼ no asthma symptoms present; 1 ¼ asthma symptoms present, but caused no discomfort; 2 ¼ asthma symptoms caused discomfort, but did not interfere with daily activities or sleep; 3 ¼ asthma symptoms interfered somewhat with daily activities or sleep; 4 ¼ asthma symptoms interfered with most activities, and may have required that the participants stay home in bed, return home early from school or work, or call a doctor or nurse for advice; 5 ¼ asthma symptoms required either going to a hospital, emergency room, or outpatient clinic.
Subjects also recorded in the diary the daily number of asneeded b-agonist inhaler puffs and other asthma medications. Detailed explanations of questions and possible answers for asthma symptom levels and respiratory infections were included on the reverse side of the diary. A blank comment section was available for subjects to report problems.
We used the Mini-Wright peak flow meter (Keller Medical Specialties Inc., Antioch, IL, USA) to determine PEF. This technique was adopted for reasons of economy, although it has two major limitations in our context: it is insensitive to small-airway obstruction, and offers no protection against fabricated or falsified data. Subjects were trained by staff and given written instructions on the how to perform expiratory maneuvers. They were instructed to take PEF measurements before the use of inhaled bronchodilators. The highest of three values from consecutive PEF maneuvers in the morning and in the evening were retained for the analysis. An acceptable target for PEF reproducibility within a test session has been determined by an expert panel to be a difference of 10% or less (Enright et al., 1995) . We found that 410% difference between the highest and second highest PEF occurred on 17.8% of all morning and evening PEF test sessions. These PEF data were excluded from analysis, although their inclusion made little difference in the results presented below. Trained research assistants also administered a baseline and an end-of-study spirometry test session to aid in the assessment of asthma severity using FEV 1 .
Central Site Air Pollution Measurements
Owing to power company delays, outdoor air sampling by the South Coast Air Quality Management District (SCAQMD) at the chosen central site did not start until November 19, 1999. Data were obtained on November 4-18 at a nearby SCAQMD site, which was nearer to eight out of 26 volunteers than the planned site. There was an SCAQMD staff holiday break in ambient VOC collection on December 25 and 26, and December 31, 1999 through January 4, 2000. In all, 24-h outdoor air samples for VOCs were collected in canisters using the XonTech 91OA (XonTech Inc., Van Nuys, CA, USA) and analyzed using EPA TO-14 methodology with gas chromatography-mass spectrometry (GC-MS) (SCAQMD, 2000) . Some measurements of ambient styrene (48%) and ambient p-dichlorobenzene (27%) were below the method detection limit (MDL); for these days, values were set at half the MDL of 0.05 ppb. In addition to VOCs, criteria air pollutant gases (O 3 , NO 2 , SO 2 , and CO) were monitored at both sites using standard methods beginning on November 11, 1999 and continuing daily through January 23, 2000. Particle mass data were limited to a 24-day period providing insufficient overlap with breath VOC sample days. Therefore, our analyses of criteria pollutants are limited to gases.
Breath VOC Measurements
Coinvestigators at the Research Triangle Institute manufactured the breath samplers described previously (Raymer et al., 1990) . Briefly, during a 2-min collection period, the participant inhales activated-carbon-filtered air and exhales into an evacuated stainless steel SUMMA canister in such a way that the sample represents air from peripheral airways and alveoli. When collecting the canisters, the field team checked the valve before removing the canister from the breath unit.
Canisters were analyzed using an autosampler (Entech Instruments, Inc., Model 7016A) connected to GC-MS (Hewlett-Packard Model 5973). Prior to analysis of samples, six calibration standards were used to construct a calibration curve for each target analyte, covering the expected concentration range of the samples down to the estimated MDL.
Of 12 target breath VOCs, four compounds were not included in the analysis because they were detected for only 18% or fewer of the samples: 1,1-dichloroethane, carbon tetrachloride, chloroform, and o-dichlorobenzene. The most frequently detected of these were two industrial processrelated VOCs, carbon tetrachloride and chloroform, which had only 9 and 15 person-observations above the MDL, respectively. The eight compounds analyzed, quantifiable in 75% or more of the breath samples, included four petroleumrelated VOCs (toluene, m,p-xylene, benzene, and o-xylene) and four industrial process-related VOCs (methylene chloride, styrene, tetrachloroethylene, and p-dichlorobenzene). There are also indoor sources for some of these compounds. For example, p-dichlorobenzene can be released from mothballs and other insect repellants or deodorizers. For samples below the MDL, values were set at half the MDL.
We originally aimed to have subjects give breath samples during around four ''asthma event'' days and four ''baseline'' symptom-free days. Subjects were instructed that an asthma event occurred when asthma symptoms required the use of as-needed bronchodilator medications, generally metered dose b-agonist inhalers. A baseline day was defined as one with no asthma symptoms that day or the previous 2 days.
The 3-day time interval is based upon the resident times of the target compounds, which may extend to 3 days in the socalled fourth phase of VOC retention in adipose tissue (Wallace et al., 1996) .
Although we aimed to recruit subjects with more persistent asthma who would have a sufficient number of event days, as described below, the severity of asthma during the study was mild-intermittent in the majority of subjects. Therefore, a minority of breath samples occurred on days when subjects reported in their diaries that asthma symptoms were bothersome or interfered with daily activities. Some subjects reported to staff that certain breath canisters were for asthma event days, but diary data contradicted that information. Subjects may have been trying to please staff by such reports because it was emphasized to subjects that we aimed to collect a balanced number of event and baseline samples. We chose to use concurrent daily information reported in the diaries on symptom severity and PEF rather than weekly verbal reports of canister classifications. Therefore, for the analysis of exposure-response relationships, subjects could have reported asthma symptom responses without use of as-needed asthma medications or interference with daily activities as described below in the Analysis section.
A total of 131 breath canisters were collected from the 21 subjects. A total of 15 canister days had no diary data. Eight of these observations occurred because subjects had completed diary follow-up before the Christmas holiday period, but continued to give breath samples. The remaining seven missing diary observations represent gaps in the subjects' follow-up due to noncompliance. An additional eight observations had missing asthma symptom score data but PEF was reported. The final number of VOC breath canisters available was 108 for the analysis of symptoms and 116 for PEF. One subject gave only one sample. The rest gave 3-12, with a median of five samples.
Analysis
The regression analysis of pollutant effects on asthma symptoms reported in the diary was based on a dichotomous outcome variable with a cutoff point between an asthma symptom score of 1 and 2. This variable represented the risk of asthma symptoms that were bothersome or more severe as compared with no symptoms or symptoms not bothersome. Symptoms not considered by the subject to be bothersome (score ¼ 1) are not likely to be clinically relevant and therefore are in the referent category. This approach has been successful in detecting robust symptom associations with air pollutants and aeroallergens in sensitive populations of asthmatics studied in our previous asthma panels (Delfino et al., 1996 (Delfino et al., , 1997 (Delfino et al., , 1998 .
Effect estimates for asthma symptoms will be expressed as odds ratios with 95% confidence intervals for minimum to mean increases in the air pollutant. Conceptually, this approach allows strengths of association for different pollutant metrics to be compared regardless of the units of measurement or concentration range of normally distributed regressors. We utilized generalized estimating equations (GEE) for regression analyses of the symptom variables. The GEE model is suitable for non-normal response data that are discrete and correlated (Liang and Zeger, 1986 ). Repeated daily measurements over time in individuals constitute a cluster of correlated observations. The GEE models were tested using the logit link in the SAS generalized linear model procedure Genmod, version 8.2 (SAS, 2000) . The fit of the models was tested with deviance statistics. There was no significant serial correlation in the models because breath samples were collected many days apart. The best working correlation was exchangeable correlation; in other words, the binary responses for individual subjects were assumed to be equally correlated.
Only eight out of 110 available symptom reports (7%) on the day following the breath sample (lag 1) stated that asthma symptoms were bothersome or worse. In contrast, 21 out of 108 available symptom reports (19%) on the same day as the breath sample (lag 0) stated that asthma symptoms were bothersome or worse. It is for this reason that analyses of lagged breath VOCs were not performed for symptoms. Symptom effects of lag 0 breath VOCs will be compared with lag 0 ambient VOCs.
For the regression analyses of PEF, we employed the general linear mixed model, which estimates both fixed and random effects (Littell et al., 1996) and is particularly suitable for correlated data in individuals (Jennrich, 1986) . We used the SAS Mixed procedure, version 8.2 (SAS, 2000) that optimizes a restricted maximum likelihood function by using the Newton-Raphson algorithm (Lindstrom and Bates, 1988; Littell 1996) . Random intercepts were estimated for each individual. This indirectly controls for anthropomorphic differences that lead to lung function differences. The fit of the models was tested with Akaike's information criterion (AIC). Again, there was no significant serial correlation because breath samples that were collected many days apart. The best fitting covariance structure by AIC was variance components.
Lag pollutant models did not show any association between evening PEF deficits and lagged exposures or between morning PEF deficits and exposures 2 days in the past. Therefore, for simplicity, evening PEF was regressed on VOC concentrations on the day subjects performed the breath-sampling maneuver (lag 0) and morning PEF from the following day was separately regressed on the same breath VOC concentrations, which are then referred to as exposure lag 1. Given that the breath samples were given toward the end of the day, morning PEF for the same day is less temporally relevant than morning PEF for the following day.
In models for both asthma symptom episodes and PEF, independent relationships were examined for individual VOCs and for criteria air pollutant gases (O 3 , NO 2 , CO, and SO 2 ). Regression models for the air pollutants were then tested for confounding by weekend versus weekday, maximum temperature at the central sites, and respiratory infections. Generally, confounding was considered to be a 10% or greater change in the regression parameter estimate for the exposure of interest. Between-pollutant confounding was then tested with two-pollutant regression models including an individual VOC with a criteria air pollutant gas. Table 1 shows the characteristics of subjects and describes outcomes for panel days when they gave VOC breath samples. The panel is described by the number of days that subjects had asthma symptoms that were bothersome or more severe. Across the 3-month daily panel, only five subjects had any asthma symptoms (score 40) on more than two times a week throughout the study. The remaining 17 subjects were considered to have mild intermittent asthma Defined as daily diary reports of symptoms on >two times a week throughout the study (NHLBI, 1997), irrespective of asthma medication regimen, from all person-days of observation during the study.
Results
Descriptive Statistics
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based on symptom frequency alone, irrespective of asthma medication regimen (NHLBI, 1997) . Five of these subjects were asymptomatic, and one other had no asthma symptom scores over 1 (i.e., no bothersome or more severe symptoms). Nevertheless, their data were included in the analyses to retain between-subject differences in exposure-response relationships. In addition, their PEF data were still potentially informative and were used in the PEF analysis.
Percent predicted FEV 1 were calculated from prediction equations for Hispanic children (Hankinson et al., 1999) to identify moderate persistent asthma severity if predicted FEV 1 is o80% (NHLBI, 1997). Five had o80% predicted FEV 1 at both pre-or poststudy spirometry sessions, while seven had o80% predicted FEV 1 at the prestudy session only and two at the poststudy session only. Four of these 14 subjects also had asthma symptoms more than two times per week on average. Asthma symptoms more than two times per week were reported in two of six subjects taking antiinflammatory medications regularly (33%) and three of 16 subjects not taking anti-inflammatory medications (19%) (not in Table 1) . Table 2 shows univariate statistics for exposure data. Ambient VOC data are from the stationary outdoor monitoring sites, and match the available person-days of observation for breath VOCs. As the distributions of the breath VOC concentrations were log normally distributed, we log-transformed the exposures prior to regression analysis. Table 2 also shows outdoor ambient measurements The number of ambient observations used in univariate statistics is the person-days of exposure data available from the subset of days when 21 subjects gave exhaled breath samples for VOCs. Fewer person-days of observation were obtained for ambient than for breath measurements due to sampling or deployment problems. Differences in the number of breath VOCs are due to inability to calculate concentration from GC-MS interference, particularly for methylene chloride.
b
The South Coast Air Quality Management District made ambient air pollution measurements at the stationary outdoor monitoring sites. There was no ambient VOC monitoring during December 25 through 26, and December 31 through January 4. c Many days for ambient styrene (41) and ambient p-dichlorobenzene (24) were below the method detection limit (MDL); for days below the MDL, values were set at half the MDL (0.05 ppb).
of criteria air pollutant gases from the same subset of persondays. Concentrations of ambient pollutants were approximately normally distributed. Concentrations of criteria pollutants were always below the U.S. NAAQS. Table 3 shows the Spearman rank correlation matrix between breath and ambient VOCs. Correlations were low between like VOCs (diagonal row in dark font) and significant only for benzene and tetrachloroethylene. Both ambient and breath benzene were correlated with several of the other VOCs in breath or in ambient air, respectively. Breath benzene and tetrachloroethylene were weakly, but significantly, correlated with most of the ambient VOCs. Correlations between breath VOCs were high (R, 0.7-0.9) for the petroleum-related VOCs, but much weaker for the other VOCs (Ro0.3) (not shown). Correlations between ambient air pollutants are shown in Table 4 . To establish relevance to the regression modeling, paired observations are from the subset of person-days when subjects gave breath samples. Except for O 3 , most ambient pollutants were moderately to strongly correlated with each other. This was likely due to common pollutant sources and meteorological determinants, including air stagnation. Correlations between toluene and xylene compounds were particularly strong (R40.9). Criteria pollutant gases were weakly correlated with breath VOCs (Ro0.35, not shown). Table 5 shows results of GEE models for risk of asthma symptom episodes (bothersome or more severe) in the 21 asthmatic children versus log-transformed breath VOCs with no covariates in the model. Geometric means and geometric standard deviations for the VOCs are also shown for asthma symptom episode versus referent days. Most models gave no clear suggestion of an adverse effect (P-values 40.2). The benzene model was suggestive of a positive association. These models were further tested for confounding by temperature, respiratory tract infections, and weekend.
Regression Analysis of Asthma Symptoms
We first examined relationships between the covariates and breath VOC concentrations. GEE models for the categorical covariates showed small nonsignificant relationships of respiratory infections to breath benzene (odds ratio (OR) 2.26, 95% confidence interval (CI) 0.62, 8.25). Breath VOCs were not significantly different across weekends versus weekdays. Spearman correlations between breath VOCs and temperature were very small (ro0.13) and nonsignificant. We then examined the relationship of the asthma outcomes to respiratory infections, weekend, and temperature. Each independent control variable was tested alone in GEE models. As discussed above, respiratory infection data for two subjects were in error and were excluded. Respiratory infection reports were significantly associated with asthma symptom episodes (OR 4.82, 95% CI 2.42, 9.60). Maximum daily temperature was associated with risk of asthma symptom episodes (b ¼ 0.040170.0216). Reports of asthma symptom episodes were not different between weekends versus weekdays (OR 0.92, 95% CI 0.54, 1.58).
Given the above findings, multivariate GEE models were tested for the risk of asthma symptom episodes from breath levels of benzene and toluene (VOCs where univariate GEE models suggested a possible relationship to asthma symptoms) controlling for temperature and respiratory infections. We compared models of breath VOC alone to models of VOC with the control variables. As multivariate models controlling for respiratory infections are not strictly comparable to models for VOCs alone, we compared the two model types excluding observations for the two subjects with invalidated respiratory infection data. These two subjects each gave four breath VOC samples, but only one sample was given on a day with an asthma symptom episode. There was no significant interaction between breath VOCs and respiratory infections. Models for the risk of asthma symptom episodes from breath benzene were not confounded by respiratory infections or temperature. The OR for the model with benzene alone was 2.17 (95% CI, 0.84, 5.56) and for the multivariate model was 2.03 (95% CI, 0.80, 5.11). The respiratory infection variable was still significant in the multivariate model with breath benzene. Models for the risk of asthma symptom episodes from breath toluene suggested possible confounding by respiratory infections and temperature, but confidence intervals were wide. The OR for the model with breath toluene alone was 1.80 (95% CI, 0.50, 6.48) and for the multivariate model was 1.58 (95% CI, 0.43, 5.79). The decrease in the parameter estimate for toluene was attributable to temperature. Analogous multivariate models were tested for ambient benzene and toluene, which showed notably stronger associations with symptoms than breath VOCs. We found a small amount of confounding of effects from ambient benzene by temperature. ORs were as follows: for the model with ambient benzene alone, the OR was 6.54 (95% CI, 2.02, 21.1); and for the multivariate model with temperature, the OR was 6.06 (95% CI, 1.69, 21.7). For ambient toluene, we found a small amount of positive confounding by respiratory infections and negative confounding by temperature. ORs were as follows: for the model with ambient toluene alone, the OR was 5.19 (95% CI, 1.43, 18.8); for the multivariate model with respiratory infections, the OR was 5.66 (95% CI, 1.58, 20.3); and for the multivariate model with temperature, the OR was 4.96 (95% CI, 1.38, 17.8). A pattern of modest confounding similar to that of ambient toluene and benzene was found for most of the remaining ambient VOCs as well as ambient criteria pollutant gases. Therefore, all models for both breath VOCs and ambient pollutants control for respiratory infections and temperature. This approach maintains comparability between the different pollutant models. Table 6 shows results of the multivariate GEE models for asthma symptom episodes in relation to concentrations of lag 0 breath VOCs as compared with lag 0 ambient VOCs measured on the same days as the breath samples. Table 6 also shows effects of lag 0 ambient criteria gases. Ambient benzene was significantly and strongly associated with asthma symptom episodes. The pollutant mean effect on risk of symptoms was notably higher than the mean effect of breath benzene. The OR for breath benzene was also not significant (Po0.14). Ambient toluene was significantly and strongly associated with asthma symptom episodes. Its OR was notably higher than breath toluene, which showed a lower 95% confidence limit well below 1.0. Ambient m,pxylene was significantly associated with asthma symptom episodes, whereas breath m,p-xylene showed an OR of 1.00. Ambient o-xylene was also associated with asthma symptom episodes, but breath o-xylene was not. Neither breath nor ambient concentrations of methylene chloride, styrene, tetrachloroethylene, or p-dichlorobenzene were significantly associated with symptoms. Compared with breath tetra- 
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chloroethylene, ambient tetrachloroethylene showed a larger OR, consistent with relative differences for other significant ambient VOCs. Results for ambient criteria gases shown in Table 6 are as follows. Ozone was not associated with asthma symptom episodes. The 1-and 8-h maximum NO 2 variables were strongly associated with asthma symptom episodes, although confidence intervals were wide. The risk of asthma symptoms was seven or more times higher for an increase to the mean ambient NO 2 level. The 1-and 8-h maximum SO 2 variables were also associated with asthma symptom episodes. The magnitudes of association for SO 2 were smaller than for NO 2 , with ORs of around 2. Carbon monoxide was not associated with symptoms.
The following is an analysis of potential confounding by criteria pollutant gases of associations between asthma symptoms and VOCs. Two-pollutant models were tested for the ambient VOCs (benzene, toluene, and m,p-xylene) and criteria pollutant gases (NO 2 , SO 2 ). These pollutants were most clearly associated with symptoms. Single-pollutant models are compared with two-pollutant models for the same subset of 67-70 nonmissing person-days for both pollutants. Table 7 shows that comparing single-to two-pollutant models, ORs decreased and CIs widened, often to a considerable extent, for both the VOC and criteria gas. Generally, regression parameters decreased by about 25-50%. The most stable parameters were for SO 2 in models with toluene or m,p-xylene. The results show that there is instability in regression parameters along with inflation of variance in the two-pollutant models, possibly due to moderate to strong correlations between the VOCs and criteria gases (Table 4) . Two-pollutant models using the 8-h averaging times of NO 2 and SO 2 were similar.
Regression Analysis of Peak Expiratory Flow
Mixed models for morning and evening PEF were separately tested for confounding by temperature, respiratory tract infections, and weekend. Maximum daily temperature was not associated with PEF (P40.4) and did not confound VOCs. PEF was not different on weekends compared with weekdays (P40.6) and did not confound VOCs. There was a significant inverse association between evening PEF and reports of respiratory infections, and parameters for the VOCs generally increased in models including respiratory Mean VOC concentration is for days with nonmissing diary data and is shown in Table 2 .
b OR and 95% CI are from generalized estimating equations, and estimate the relative risk of an asthma symptom response among 21 asthmatic children for an arithmetic mean change in log-transformed VOC breath concentration.
infections. There were no significant interactions between respiratory infections and VOCs in mixed regression models (P40.3). The effect of lag 0 respiratory infection was À44 l/ min (Po0.002) on evening PEF of the same day. For the following day's morning PEF (included in lag breath VOC models), the effect of a lag 1 respiratory infection was À15 l/ min (Po0.3) on morning PEF. Figure 1 shows results of mixed regression models for PEF versus mean increases in log breath VOC concentrations, controlling for respiratory infections. These models are compared side-by-side with models for PEF versus mean increases in the same ambient VOCs. Most models for breath VOCs showed no suggestion of an association (P40.2). A significant decrease in evening PEF of À29 l/min was found for a mean increase in breath tetrachloroethylene. There was no association with ambient tetrachloroethylene. A significant decrease in evening PEF of À21 l/min was found for a mean increase in ambient benzene. Borderline significant deficits in evening PEF were found in relation to ambient methylene chloride (Po0.08) and ambient toluene (Po0.09). Remaining models were not significant (P40.2), but parameters were negative for xylene compounds. Figure 2 shows results of mixed regression models for PEF versus mean increases in 1-h maximum ambient criteria pollutant gas concentrations measured on the same day as the breath sample. A significant decrease in evening PEF of À13 l/min was found for a mean increase in ambient 1-h SO 2 . There was also some suggestion of deficits in evening PEF with mean increases in 1-h NO 2 (Po0.13). Results for 8-h maxima were similar, with a somewhat greater effect and tighter CI for 8-h CO (À20.4 l/min, 95% CI, À45.6, 4.71, Po0.11) (not shown).
Regression models were then tested for the relationship of evening PEF to breath tetrachloroethylene or to ambient OR and 95% CI are from generalized estimating equations, and estimate the relative risk of an asthma symptom response for a mean change in the air pollutant, controlling for respiratory infections and temperature. Models include data for 19 children (two subjects with invalid respiratory infection data are excluded). Breath VOCs were log-transformed in models. *Po0.05; **Po0.01.
benzene, controlling for those criteria pollutant gases that were associated with PEF deficits in the regression models (1-h NO 2 and 1-h SO 2 ). The association between evening PEF and ambient benzene was not confounded by 1-h NO 2 . For a mean increase in benzene, this model showed a PEF deficit of À26.3 l/min (95% CI, À51.4, À1.30). This was a slightly larger deficit than the model for benzene alone shown in Figure 1 (À21.4 l/min). However, the regression parameter for 1-h NO 2 flipped in the two-pollutant model compared with the single-pollutant model in Figure 2 and was nonsignificant (11.5 l/min, 95% CI, À30.4, 53.4). Compared with the single-pollutant models in Figures 1  and 2 , the regression model for ambient benzene and 1-h SO 2 showed that effects for both pollutants were reduced: for benzene, À15.3 l/min, 95% CI, À38.5, 7.81; for 1-h SO 2 , À6.21 l/min, 95% CI, À21.7, 9.30. The association between The South Coast Air Quality Management District made ambient air pollution measurements at the stationary outdoor monitoring sites. Mean values of pollutants are from the same day as symptom reports (lag 0) and from the subset of person-days (no. obs.) when subjects gave exhaled breath samples for VOCs.
b OR and 95% CI are from generalized estimating equations, and estimate the relative risk of a symptom response for a mean change in the air pollutant, controlling for respiratory infections and maximum temperature. Models include data for 19 children (two subjects with invalid respiratory infection data are excluded). Mean concentrations are given in Table 6 . c Single-pollutant models are for the subset of nonmissing days for both pollutants in the two-pollutant models. evening PEF and breath tetrachloroethylene was not confounded by 1-h NO 2 . For a mean increase in breath tetrachloroethylene, this model showed a PEF deficit of À28.3 l/min, 95% CI, À59.0, 2.43. This was similar to the model for tetrachloroethylene alone in Figure 1 . Compared with the single-pollutant model in Figure 2 , the regression parameter for 1-h NO 2 was smaller and the CI wider in the two-pollutant model: À17.7 l/min, 95% CI, À51.9, 16.6. The regression model for breath tetrachloroethylene and 1-h SO 2 showed little change in either pollutant's regression parameters compared with the single-pollutant models.
In conclusion, two-pollutant models gave no clear evidence that ambient criteria pollutant gases confounded the significant effects of either ambient benzene or breath tetrachloroethylene on evening PEF. However, as with the two-pollutant models for symptoms, problems of multicollineariry were suggested in some models given the instability in both regression parameters along with inflation of variance.
Discussion
Summary of Findings 1. A possible association was found between asthma symptom episodes (bothersome or more severe asthma symptoms) recorded in diaries and breath concentrations of benzene. 2. Other breath VOCs were not associated with asthma symptom episodes. 3. An analysis of ambient VOCs measured on the same person-days as breath VOCs showed notably stronger associations with symptoms. These included the petroleum-related VOCs benzene, toluene, m,p-xylene, and o-xylene. 4. Associations were also found between asthma symptom episodes and ambient concentrations of 1-h maximum and 8-h maximum NO 2 and SO 2 , but not O 3 or CO. 5. Consistent deficits in morning and evening PEF were found for breath benzene, and ambient benzene, toluene, and xylene compounds, but most 95% CIs crossed 0. 6. Consistent deficits in evening PEF were found for NO 2 and SO 2 . 7. There was no clear evidence that NO 2 or SO 2 confounded VOC effects on symptoms or on PEF.
Analysis of Breath Versus Ambient VOCs
The comparison of exhaled breath VOCs with ambient VOCs measured on the same person-days showed some interesting inconsistencies. Ambient benzene was significantly and strongly associated with asthma symptom episodes (OR 5.93, Po0.01), whereas the effect of breath benzene for the same subset of person-days was much smaller (OR 2.03, Po0.14) (Table 6 ). Similarly, strengths of association with asthma symptom episodes for toluene, tetrachloroethylene, m,p-xylene, and o-xylene were larger for ambient than breath samples. If the VOC compounds analyzed are causally related to acute asthma, then the expectation is that a biomarker of exposure like exhaled breath concentrations of VOCs would be more strongly associated with symptoms than ambient measurements. We offer three hypotheses to explain these findings, as follows:
1. ambient measurements may be serving as better surrogates for true causal air pollutants in ambient air than breath VOCs, which, like personal VOC exposures, are not notably linked to outdoor levels; 2. breath concentrations may less accurately reflect pulmonary doses during the time frame relevant to acute responses; and 3. weak causal strengths of VOCs were not detected by the small sample sizes of breath VOCs, and systematic or random biases led to associations with ambient VOCs for the subset of person-days when breath samples were given.
Hypothesis 1 Ambient measurements of VOCs may track other ambient air toxics, ultrafine particles or other unmeasured pollutant gases that may be more causally related to acute asthma outcomes than the measured VOCs. Breath VOCs, on the other hand, are likely to be influenced by other nonambient sources in locations such as indoor home or other microenvironments. There were weak correlations between breath VOCs and outdoor VOCs used in the epidemiologic analysis (Table 3 ) (e.g., benzene, r ¼ 0.30). This supports the notion that personal VOC exposures are not notably linked to outdoor levels, which is consistent with the overall results of the EPA TEAM Study (Wallace et al., 1991) . We have supporting evidence for this as well. Another component of the present study involved exposure assessments, including time-activity diaries to assess VOC exposures, and personal and indoor passive VOC samplers in a subset of four subjects. Detailed results of this research are to be presented elsewhere. Briefly, four volunteers were recruited from the 24 participants in the panel for 5 weeks of exposure measurements of daily personal VOC (129 passive badges) and indoor home VOC (129 passive badges). They recorded in diaries their activities relevant to exposures. We found that the ratios of breath VOC/indoor VOC were less than 1. Breath/personal VOC ratios were also less than 1 for all the compounds, except for p-dichlorobenzene. Personal VOC exposures were correlated with indoor VOC exposures (r ¼ 0.74-0.91), but did not correlate with outdoor measurements for most VOCs (r ¼ À0.02-0.18), except tetrachloroethylene, r ¼ 0.45. Outdoor styrene and m,p-xylene of the previous day were weakly associated with current-day personal exposures. Timeactivity diary data had limited predictive power for either personal or breath VOC.
Criteria air pollutant gases could be among the causal agents in ambient air explaining the difference in association between breath and ambient VOCs. However, problems of multicollinearity prevented a clear interpretation of interpollutant confounding for symptom models with an ambient VOC variable and a criteria gas variable (Table 7) . Regardless, it may be inappropriate to use multipollutant modeling to test independent air pollutant effects by treating one or the other pollutant as a confounder if the pollutants are surrogates for some underlying causal mixture. The controversy over this issue remains to be resolved, although some resolution may be possible through the use of personal exposures, which may be less correlated than ambient measurements (Sarnat et al., 2001) .
Hypothesis 2 Even if VOCs are causal, breath concentrations may not accurately reflect pulmonary doses during the time frame relevant to acute responses to VOCs. This is because the kinetics of VOC exhaled air concentration as it relates to exposure and to metabolism is complex. Breath sample VOC concentrations have been estimated to reflect some components in the first compartment (blood) from exposures in the half hour prior to the breath sample, in the second compartment (vessel-rich tissues) from exposures in the prior hour and up to 4 h in the past, in the third compartment (other vessel-poor tissues) from exposures in last several hours up to 12 hours in the past, and in the fourth compartment (fatty tissue) from exposures occurring up to 3 days in the past Pellizari et al., 1992; Wallace et al., 1993 Wallace et al., , 1996 . Therefore, breath VOCs reflect cumulative personal exposures to variable degrees depending on the time course of exposures and metabolic factors that determine the half-life of the VOC (which varies between VOCs). This is reflected in the results of the U.S. EPA TEAM Study of 800 people, which showed that correlations between breath and personal air measurements were significant (Po0.0001) but small (correlation coefficients 0.3-0.4) (Wallace et al., 1996) . Thus, the relationship between asthma episodes and breath VOC samples may be limited in accuracy because of the interplay between the halflife of the VOC and the causal temporality of the exposures. Similarly, the accuracy of the estimated relationship between asthma episodes and ambient air VOCs may be a function of the length of period over which the time-weighted average is obtained prior to the episode. The VOC concentrations in ambient air (as collected here) represent a time-weighted average value over the 24-h sampling time period. In addition, we may have also missed bronchoconstrictive responses to short-term peak exposures, which could occur at times distant to the breath sample, and which may also not be reflected by the 24-h average ambient measurements. Although we do not know what the optimal ambient air sampling time should be, these results suggest that it is likely to be longer than the half-life of the VOC. The optimal sampling time frame for understanding whether VOCs are involved in asthma exacerbations would need to be determined using real-time measurements.
Hypothesis 3 We may have had insufficient power to detect adverse effects given the limited number of breath VOC observations. For instance, the number of breath analyses was limited to 106 person-days in 21 subjects in the univariate models (Table 5) . Adjusted ORs for breath VOCs (Table 6 ) have noticeably wide confidence intervals, an indication of a sample size too small to detect a moderately sized effect if it existed. We conducted a power analysis using the results in the present study, although the appropriateness of this approach is controversial (see Levine and Ensom, 2001 ). However, we do not present so-called observed power based on the given ORs. This is because post hoc power calculations do not contribute more information than is already given by the reported CIs. Any negative study could be dismissed on the grounds that its power was too low. We conducted Monte Carlo simulations to estimate the magnitude of association that would yield at least 80% power given the sample sizes in the present study. We completely specified a statistical model and data generation process to generate the binary symptom outcome variable. First, predictor variables were generated so that their distribution mimicked the sampling distribution of actual data, including breath benzene, breath toluene and the covariates respiratory infection and temperature. Various magnitudes of association were used to generate data, while other model parameters were chosen so that the outcome variable also displayed a distribution similar to that observed in actual data. The outcome variable was generated using this fully specified model. GEE estimates were computed and relevant tests of hypotheses were conducted. The process was repeated 200 times for each data set and power was computed based on frequencies associated with the test results. Results of this prospective-type power analysis specified that for a sample of this size, power of at least 80% would be achieved only if the true effect corresponded to ORs in excess of 6.1 and 6.7 for breath benzene and breath toluene, respectively. The significant findings for symptoms and ambient VOC exposures on canister days may have been a function of the larger magnitudes of association. On the other hand, the significant findings for ambient exposures could have occurred as a result of some bias in the subject-selected sampling schedule for breath canisters. However, we found consistency between the analysis of asthma symptoms and the analysis of PEF in relation to ambient exposures, which is a more objective outcome. A significant decrease in evening PEF of À21 l/min was found for a mean increase in ambient benzene, but not for breath benzene (À10 l/min, Po0.27). Borderline significant deficits in evening PEF of À16 l/min were found in relation to ambient toluene (Po0.09) but not breath toluene (À5 l/min, Po0.64). Effects of NO 2 and SO 2 on PEF were also consistent with the symptom analysis. We view it as unlikely that subjects gave breath samples on days they perceived high exposures, lower lung function, and worsened symptoms.
Some contrasts between PEF versus symptom analyses were found. A significant decrease in evening PEF of À29 l/ min was found for a mean increase in breath tetrachloroethylene. However, breath tetrachloroethylene was not significantly associated with asthma symptoms. There was no association of PEF with ambient tetrachloroethylene, whereas the symptom analysis showed a possible increased risk of asthma symptom episodes from ambient tetrachloroethylene exposures (OR 1.94, 95% CI, 0.80, 4.70). Borderline significant deficits in evening PEF were also found in relation to ambient methylene chloride (Po0.08), whereas there was no association with symptoms. Possible explanations for difference between findings for symptoms and PEF are as follows. PEF in the evening when most breath samples were given might reflect effects of very recent exposures on bronchomotor tone. Such recent acute effects could be better captured by breath samples from VOC components in the first and second compartments (see the discussion under Hypothesis 2). In addition, PEF is largely a measure of large airways function, whereas a mixture of large and small airways obstruction drives asthma symptoms. Initial increases in asthma symptoms that eventually become clinically important asthma exacerbations may occur before reductions in PEF (Chan-Yeung et al., 1996) .
The statistical significance of the association of PEF deficits with breath tetrachloroethylene (one out of 16 breath VOC models tested) could have occurred by chance. The same assessment with regard to statistical significance can be made for the association of PEF deficits with ambient benzene. However, it is of note that PEF deficits more than À2 l/min were found for regression parameters in 10 out of 16 models for breath VOCs and 12 out of 16 models for ambient VOCs, although some deficits were small and had wide confidence intervals (Figure 1) . No changes were 410% of overall mean PEF. The two-pollutant models gave no evidence that ambient criteria pollutant gases confounded VOC effects.
Our previous results involving daily ambient data in this panel showed consistent associations of asthma symptoms with the same ambient VOCs (benzene, tetrachloroethylene, toluene, mp-xylene, and o-xylene) as well as ambient NO 2 and SO 2 (Delfino et al., 2003) . Similar to the present results, two-pollutant regression models including an individual VOC with a criteria air pollutant gas did not clarify whether associations were due to one or the other pollutant. Analyses of asthma symptoms in relation to ambient particulate air pollution data showed that the strongest and most robust association was with PM 10 organic carbon followed by PM 10 elemental carbon, then PM 10 total mass.
Consistency with other Epidemiological Studies
Cross-sectional and case-control studies of children have shown associations of allergic responses, asthma symptoms, and prevalence of asthma or allergic sensitization with proximity to high home or school traffic density (particularly truck traffic) (Delfino, 2002) . These data are coherent with our present panel study findings of acute exposure-response relationships in an area with high traffic density. Other literature on community asthma and indoor VOCs such as formaldehyde (Delfino, 2002) , and studies of occupational asthma and air toxics (Bernstein et al., 1999) , suggest that asthma is an illness relevant to the hazardous effects of air toxics in addition to cancer, neurological illnesses, and congenital defects.
As discussed, the only other epidemiologic study in the US that evaluated ambient VOC exposures in relation to respiratory health in children showed small positive associations of VOCs with lower respiratory symptoms and with prevalence of asthma diagnoses in the industrial area of Kanawha Valley, WV (Ware et al., 1993) . To our knowledge, only three epidemiologic time series investigations of aggregate hospital data have evaluated effects of specific air toxics on respiratory diseases, and all of these support our general finding that criteria air pollutants did not clearly show stronger or more robust associations than VOCs. Thompson et al. (2001) found associations between emergency room visits for asthma by children and ambient benzene in Belfast, Northern Ireland. Smaller significant associations were found for criteria air pollutants (PM 10 , NO 2 , SO 2 , and CO). Hagen et al. (2000) studied hospital admissions for aggregate respiratory diseases in Drammen, Norway and also found stronger associations for benzene than for criteria air pollutants. They also found significant associations for toluene and formaldehyde at magnitudes similar to the criteria air pollutants. Both studies found that effects of the VOCs were more robust in two-pollutant models than PM 10 . Another time series investigation in London evaluated an extensive database of hydrocarbon data and found that most of the hydrocarbons, including benzene, toluene, 1,3-butadiene, ethylbenzene, m,p-xylene, and o-xylene, were associated with emergency room visits for symptoms of acute wheeze in children less than 2 years old (Buchdahl et al., 2000) . Effects of criteria pollutants (PM 10 , NO 2 , SO 2 ) were of similar magnitude but CIs were wider, and O 3 showed a U-shaped relationship across seasons. This was attributed to low O 3 , but high air toxics during the winter. In conclusion, these studies suggest that the lung may be responding to a large number of compounds, and that attributing effects to any one agent ignores the importance of the mixture.
Conclusions
The main contribution of the present exploratory study is that it provides preliminary evidence of acute adverse effects of air toxics on asthma in children. Overall, the literature on the relationship of asthma exacerbations to air pollutants provides sufficient evidence to justify further advancements in etiologic research of sensitive subpopulations to improve understanding of causal components. Asthma may represent a key sentinel for the effects of toxic compounds on diseases of the pulmonary system.
Given the high traffic density of the region, stronger associations for ambient than for breath VOCs suggest that VOCs were markers for other combustion-related compounds perhaps causally related to acute asthma, and better represented with ambient measurements. To evaluate this possibility, an improved study approach is needed, including a more extensive evaluation of:
1. other correlated air toxics exposures in ambient air such as polycyclic aromatic hydrocarbons from diesel exhaust that have been proposed to be relevant to allergic respiratory diseases (Nel, 2001; Pandya, 2002) ; 2. personal exposures, including air toxics exposures of outdoor origin versus microenvironmental exposures, with assessments of exposure sources; and 3. advancement in the approach to VOC breath sample collection, including daily longitudinal samples, and/or the use of other biomarkers of air toxics exposures.
In conclusion, our findings, coupled with experimental (Nel, 2001; Pandya, 2002) and other epidemiologic evidence in the literature (Delfino, 2002) suggest that the proinflammatory and irritant nature of traffic-related pollutants may lead to adverse respiratory health effects in asthmatic children.
